Which stocks to buy, hold or sell today? As Dalal Street enters the April 25 session, here's a look at what brokerages make of some of the key stocks that are in focus.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Stocks such as IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life Insurance, Apollo Hospitals, Macrotech Developers, and other shares are on their radar today.

Do you have any of these stocks in your portfolio?

Check out the full list of what brokerages recommend, including IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life Insurance, Apollo Hospitals, Macrotech Developers, and other stocks:

IndusInd Bank

Global brokerages are upbeat on IndusInd Bank shares a day after the private lender announced its March quarter earnings. The bank reported a 46 per cent jump in its March quarter net profit at Rs 2,043 crore on a dip in provisions and stronger core income.

 

Brokerage Rating Price Target
CLSA Buy Rs 1,500
Morgan Stanley Overweight Rs 1,525
JP Morgan Neutral Rs 1,060
Jefferies Buy Rs 1,550
Goldman Sachs Buy Raised to Rs 1,522 from Rs 1,411
Citi Buy Cut to Rs 1,380 from Rs Rs 1,411
Macquarie Outperform Rs 1,510

Maruti Suzuki

Most brokerages are bullish on Maruti Suzuki India ahead of its fourth-quarter earnings on Wednesday. Citi maintained a ‘buy’ rating, while Macquarie has an ‘outperform’ stance and Nomura gives a 'neutral' call on the stock.

 

Brokerage Rating Price Target
Citi Buy Rs 12,500
Macquarie Outperform Rs 10,508
Nomura Neutral Rs 9928

 

Zomato

 

Citi retains a ‘buy’ call, while Morgan Stanley has an ‘overweight’ call on Zomato – an online food delivery company.

 

Brokerage Rating Price Target
Citi Buy Rs 76
Morgan Stanley Overweight Cut to Rs 74 from Rs Rs 82

 

Citi in its commentary said, “Both Zomato and Swiggy have introduced monetisation in the dining out the segment. While this appears to be a limited roll-out for now, nevertheless, it is positive for medium-term platform monetization.” 

 

HDFC Life Insurance

 

Brokerage Rating Price Target
Citi Buy Rs 595
Morgan Stanley Overweight Rs 650

 

Apollo Hospitals

 

 

Brokerage Rating Price Target
Goldman Sachs Buy Cut to Rs 5,050 from Rs Rs 5,100
Nomura Buy Rs 5,107

 

Macrotech Developers

 

 

Brokerage Rating Price Target
CLSA Outperform Cut to Rs 1,048 from Rs 1,083
JP Morgan Neutral Cut to Rs 1,050 from Rs 1,100

 

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.

 

(Disclaimer: The views/suggestions/advices expressed here in this article is solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)